Warren Buffett
Berkshire Hathaway
Warren Buffett Organon & Co stake
total: 135
Berkshire Hathaway OGN trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2021 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2021 Q3
According to 2026 Q2 report, Warren Buffett doesn't hold any Organon & Co (OGN) shares. To date, the estimated cost basis is nearly $30.26 for "buy" trades and estimated average "sell" price is $30.26. Berkshire Hathaway first purchased OGN in 2021 Q2, initially acquiring about 1.55M shares. Since the initial investment in Organon & Co (OGN), Berkshire Hathaway has made 1 more transaction.
When did Warren Buffett sell Organon & Co (OGN)?
Warren Buffett sold off the entire Organon & Co (OGN) position in 2021 Q3.
When did Warren Buffett buy Organon & Co (OGN)?
Warren Buffett first invested in Organon & Co (OGN) in 2021 Q2 at the reported quarter-end price of $30.26 per share.
What's the cost basis of Berkshire Hathaway's OGN stake?
The estimated cost basis for Organon & Co (OGN) stake is around $30.26 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $30.26
- Weighted AVG sell price:
- $30.26
Warren Buffett's historical trades in Organon & Co
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q3
|
0.00%
|
0
|
$30.26
|
|
-100% (-1,550,481)
|
-0.02%
|
|
2021 Q2
|
0.02%
|
1,550,481
|
$30.26
|
$46,918,000
|
new
|
+0.02%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.